Universal Vision Biotechnology Co

Universal Vision Biotechnology Co Interest Coverage

The Interest Coverage Ratio of Universal Vision Biotechnology Co (3218.TWO) as of Oct 23, 2026 is 19.00. In the previous year, Interest Coverage Ratio was 409.41 — a change of -95.36% (lower).

Interest Coverage

19.00

YoY

-95.36%

Last updated:

Interest Coverage Ratio of Universal Vision Biotechnology Co is 2024 19.00 . Interest Coverage Ratio of Universal Vision Biotechnology Co was 2023 409.41 . It decreases by -95.36% lower compared to the previous year.

The Universal Vision Biotechnology Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
8.61 TWD
Jan 1, 2018
52.14 TWD
Jan 1, 2019
80.44 TWD
Jan 1, 2020
87.46 TWD
Jan 1, 2021
66.61 TWD
Jan 1, 2022
350.65 TWD
Jan 1, 2023
409.41 TWD
Jan 1, 2024
19.00 TWD
The Universal Vision Biotechnology Co Interest Coverage history
YEARInterest CoverageYoY
19.00-95.36%
409.41+16.76%
350.65+426.39%
66.61-23.83%
87.46+8.72%
80.44+54.29%
52.14+505.83%
8.61-44.49%
15.51-47.40%
29.47+478.20%
5.10—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Universal Vision Biotechnology Co Stock analysis

What does Universal Vision Biotechnology Co do? Universal Vision Biotechnology Co., Ltd. generates revenue through the sale of optical instruments, glasses, contact lenses, and glass ornaments. The company also provides laser vision correction equipment and services, trades medical drugs, and offers leasing of medical facilities, clinic operation planning, and medical cosmetology services. Its primary market is Taiwan, where it serves customers seeking vision correction solutions and medical aesthetic treatments. The firm's product portfolio includes optical instruments, glasses, contact lenses, and glass ornaments, alongside medical drug trading. Services such as laser vision correction, medical facility leasing, clinic operation planning, and medical cosmetology are key revenue drivers. Taiwan-based customers, including individuals requiring vision care and clinics needing operational support, form the core market segment. Revenue streams are derived from the direct sale of optical products, medical drug trading, and service-based offerings like laser vision correction and medical cosmetology. The company operates exclusively within Taiwan, focusing on both consumer and clinic-level clients for its comprehensive vision and medical aesthetics solutions. Universal Vision Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Universal Vision Biotechnology Co stock

Interest Coverage Ratio of Universal Vision Biotechnology Co is 19.00 in 2024.

Interest Coverage Ratio of Universal Vision Biotechnology Co changed from 409.41 to 19.00, representing a -95.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Universal Vision Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Universal Vision Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Universal Vision Biotechnology Co

All Key Metrics — Universal Vision Biotechnology Co